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Millions of central venous catheters are placed
yearly for pressure monitoring, hemodialysis, and
delivery of fluids and medications.1 Thrombosis
associated with these catheters is a significant cause
of morbidity, particularly in patients with cancer, in
whom the incidence can be as high as 70%. Mural
thrombus that develops more centrally in the supe-
rior vena cava can be devastating. It is often assumed
that thrombosis in association with central catheters
is a result of the interaction of blood with the for-
eign body. However, repeated injury of the vessel
wall may play a more important role. Injury-induced
central vein thrombus can cause symptomatic
obstruction to venous blood flow and can surround
the catheter tip and cause device failure. We hypoth-
esize that central vein thrombosis results from repet-
itive wall injury caused by catheter-tip motion with
the cardiac cycle. We used a porcine model to test a
catheter design that uses a silicone loop to stabilize
the tip, eliminating this source of injury. 
MATERIALS AND METHODS
Experimental design and operative proce-
dures. Thirty-seven domestic swine weighing 30 to
40 kg were used. The study was approved by the
Institutional Review Board, and animal care com-
plied with the Guide for the Care and Use of
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Purpose: Thrombosis associated with central venous catheters is a significant cause of
device failure, morbidity, and loss of access sites. We hypothesized that central vein
thrombosis is caused by catheter injury to the vein wall and that it can be reduced by
stabilizing the catheter tip. To test these hypotheses, we studied central vein catheters in
a porcine model. Test catheters had a silicone-encased stainless steel loop at the
indwelling end that contacted the vein wall and stabilized the catheter tip in the center
of the vessel. 
Methods: Sealed silicon elastic (Silastic) catheters (3.2 mm outer diameter) with and with-
out a stabilizing loop were inserted via the external jugular vein into the superior vena
cava just above the right atrium. Animals were killed at 1, 2, 4, and 8 weeks, and the
vena cava was inspected for the presence of thrombus and entrapment of the catheter tip. 
Results: In control animals mural thrombus developed at the site of the catheter tip. This
thrombus organized by invasion of macrophages and smooth muscle cells, eventually
forming a lesion similar to intimal hyperplasia. Lesion cross-sectional area was signifi-
cantly smaller in animals with loop catheters than in control animals at 2 weeks (1.2 ±
1.3 vs 34.5 ± 23.9 mm2; p = 0.05) and 4 weeks (2.8 ± 0.3 vs 13.9 ± 5.8 mm2; p < 0.05).
By 8 weeks the vena cava was nearly occluded in most animals and the catheter tip was
entrapped in this lesion in all cases. Test catheters eliminated the injury process for up
to 8 weeks (p < 0.01, c 2 control vs loop catheter entrapment). Very little injury response
was found where the loop contacted the vein wall, and the catheter tip was free of
thrombus in all cases.
Conclusions: Mural thrombosis at the tip of indwelling central catheters is caused by
chronic mechanical venous wall injury. Vessel injury and the resulting thrombosis can be
prevented by a catheter modification that stabilizes the tip. Such a catheter may signifi-
cantly reduce catheter malfunction and morbidity associated with these devices. (J Vasc
Surg 1998;28:59-66.)
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Animals were fasted overnight and premedicated
with a mixture of tiletamine hydrochloride and
zolazepam hydrochloride (Telazol, Fort Dodge labo-
ratories, Inc., Fort Dodge, Iowa; 5 to 10 mg/kg)
and atropine sulfate (0.04 mg/kg) given intramuscu-
larly. After intubation, anesthesia was maintained
with inhalational isoflurane. The neck was prepared
with chlorhexidine, 70% isopropyl alcohol, and a final
application of iodine solution. A lateral longitudinal
cutdown was performed to expose the right external
jugular vein. No antiplatelet agents were adminis-
tered. In the control group standard, single-lumen,
3.2 mm Silastic central venous catheters (Bard Access
Systems, Salt Lake City) were inserted via the exter-
nal jugular vein, which was ligated around the
catheter at the insertion site. Under fluoroscopic
guidance, the catheter tip was positioned in the supe-
rior vena cava just above the right atrium. The oppo-
site end of the catheter was left in a subcutaneous
pocket after cutting off excess length. This reduced
exit-site complications and eliminated the need for
intermittent flushing of the catheter. Catheters were
sealed at both ends with silicone rubber. Animals
were killed at 1 day and at 1, 2, 4, and 8 weeks. 
At the time of vessel harvest, the animals were
anticoagulated with intravenous heparin (150 U/kg)
and killed by an overdose of sodium pentobarbital.
The chest was then rapidly opened, and the aorta was
cannulated and ligated distally. Venous drainage was
allowed through the inferior vena cava while the ani-
mals were perfused at physiologic pressure (100 mm
Hg) first with Ringer’s lactate solution until blood
was cleared and then with 10% neutral-buffered for-
malin. Venous drainage was clamped during the last
5 minutes of perfusion. The external jugular vein,
superior vena cava, and a segment of adjacent right
atrium were excised and immersion-fixed for a mini-
mum of 24 hours in the same fixative.
Loop catheters. Test catheters were identical to
controls but were modified by the addition of a sili-
cone-encased, 0.018-inch stainless steel loop at the
indwelling end (Fig. 1). This loop was designed to
contact the vein wall on opposite sides of the
catheter holding the catheter tip in the center of the
vessel.2
Histologic processing and analysis. The vein
was opened longitudinally over a distance of 1 cm
proximal and distal to the catheter tip, pinned open,
and inspected grossly for the presence of thrombus
and attachment of the catheter tip to the vessel wall.
Cross-sections for histologic examination were made
of the superior vena cava at the level of the catheter
tip and at 0.5-cm intervals along the catheter, as
depicted in Fig. 2. Care was taken to include a cross-
section through the thickest lesion identified on
gross examination. Tissues were embedded in paraf-
fin and cut in 5- m m thicknesses for microscopic
examination using hematoxylin and eosin and
Masson’s trichrome stains. A Brown and Brenn stain
was performed if infection was suspected. The cross-
sectional area of the thickest wall lesion from each
animal was measured with computer-assisted mor-
phometry using a digitizing pad and camera lucida
on a standard light microscope. Smooth muscle cells
were identified by immunohistochemical analysis
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Fig. 1. Schematic diagram of the design of the loop
catheter.
Fig. 2. Diagram of position of control (A) and test
catheters (B). Catheters enter via right external jugular
vein and are positioned with the tip just above junction
with superior vena cava. Histologic sections are taken at
the level of catheter tip (I) and along the catheter at a dis-
tance of 0.5 cm (II) and 1.0 cm (III). An additional sec-
tion was taken at the region of greatest wall thickening if
this was not included in I, II, or III. Motion of tip of con-
trol catheter is indicated by dotted lines. EJ, External
jugular vein; IJ, internal jugular vein; AX, axillary vein;
SVC, superior vena cava.
using an antibody against smooth muscle cell actin
(Boehringer Mannheim). The sections were incubat-
ed for 1 hour at room temperature with the primary
antibody. Biotinylated antimouse secondary antibod-
ies (Vector Laboratories, Inc., Burlingame, Calif.),
avidin-biotinylated peroxidase, and diaminobenzi-
dine/NiCL2 was used as the chromogen and methyl
green as the counterstain for nuclei. Specimens for
scanning electron microscopy were dehydrated
through increasing concentrations of ethanol and
dried with liquid carbon dioxide in a critical point
dryer. They were then placed on studs and sputter-
coated with gold palladium before scanning with the
electron microscope (model 35 C, JEOL U.S.A.,
Inc., Peabody, Mass.). 
Statistical analysis. The data are presented as
mean ± standard deviation. Comparisons between
cross-sectional areas for groups with small sample
sizes were made with the nonparametric, Mann-
Whitney U test, and comparison of rates of catheter
occlusion were made with c 2 analysis (statistical
package for the social sciences). Differences were
considered statistically significant when two-tail tests
yielded a p value less than 0.05. 
RESULTS
At the time of implantation, fluoroscopy revealed
significant motion of the tip of the control catheters,
which appeared to move against the vessel wall with
each heart beat. In contrast, the loop and tip of the
loop-catheters appeared to be stationary within the
vessel. 
Nine animals (five control and four test) were
eliminated from the study because they had catheter
infection that tracked from the cutdown site to the
catheter tip. The presence of infection was con-
firmed by the finding of inflammatory cells on the
hematoxylin and eosin stain and of bacteria on the
Brown and Brenn stain.
Mural injury in the superior vena cava. One
control animal was killed at 1 day to assess acute
injury to the vessel wall. Small areas of mural throm-
bus were evident on gross examination. Scanning
electron microscopy revealed patchy areas of
endothelial loss with platelet thrombus and some
fibrin deposition (Fig. 3).
Two control animals were killed at 1 week. The
superior vena cava from both animals had moderate-
ly large thrombi at the level of the catheter tip. These
had a mixed pattern typical of venous thrombus, con-
sisting of areas rich in fibrin and others containing
large amounts of red blood cells. Macrophages were
prominent in many areas of the thrombus. These
were identified by their typical cellular morphologic
features and the appearance of giant cell formation;
specific antibodies for immunohistochemical analysis
were not available. Catheter tips were free in the ves-
sel lumen in both cases.
Five control animals were killed at 2 weeks. Four
of the five had large thrombi at the level of the
catheter tip (Fig. 4). They were organizing by inva-
sion of macrophages to breakdown the thrombus
(Fig. 4). Smooth muscle cells were abundant in
these lesions (actin-positive cells). 
Three control animals were killed at 4 weeks.
Thrombi in these animals were more organized and
partially occluded the lumen. Lesions were com-
posed primarily of smooth muscle cells and had
many areas that were rich in neovascularity (Fig. 5).
Trichrome stain revealed large amounts of collagen
in the matrix. Some areas of ongoing thrombosis
were also noted. Catheter tips were embedded in the
thrombi in two of the three animals. 
Six control animals were killed at 8 weeks.
Catheter tips were entrapped in organized and near-
ly occlusive thrombus in all animals (Fig. 6). 
Effect of the Silastic loop on lesion formation
and entrapment of the catheter tip. Two animals
with loop-catheters were killed at 2 weeks. The
superior vena cava in the region of the catheter tip
had no gross thrombus. There was very little wall
thickening except for small lesions that had the
appearance of intimal thickening at sites where the
loop contacted the wall. These lesions were consid-
erably smaller than those of the control animals (1.2
± 1.3 vs 34.5 ± 23.9 mm2; p = 0.05).
Three loop-catheter animals were killed at 4
weeks. The superior vena cava in the region of the
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Fig. 3. Scanning electron micrograph of region of
endothelial damage in superior vena cava caused by
catheter tip (original magnification · 200).
catheter tip had small areas of intimal thickening
with cellular lesions, which were composed primari-
ly of smooth muscle cells. All the loop-catheter tips
were free in the vessel lumen. The cross-sectional
area of the lesions was significantly smaller in the
loop-catheter group than in the control animals (2.8
± 0.3 vs 13.9 ± 5.8 mm2; p < 0.05).
Six loop-catheter animals were killed at 8 weeks.
Catheter tips were free in the lumen in all six cases
(Fig. 7; p < 0.01, c 2 control vs loop patency). Vessel
wall damage was minimal, with only slight wall
thickening where the loop contacted the vessel wall
(lesion area, 2.7 ± 2.2 mm2).
DISCUSSION
Central venous catheters were first used in acute
care settings for delivery of intravenous therapy and
measurement of central pressures. These catheters
were made of stiff and relatively thrombogenic
materials, such as polyvinyl chloride and polyethyl-
ene, that are not suitable for long-term use.3 In the
mid-1970’s, Broviac, Schribner, Hickman, and oth-
ers developed softer catheters made of silicone elas-
tomer (Silastic, Dow Corning Corp., Midland,
Mich.).4,5 This material is a polymer consisting of
repeating pairs of silicon and oxygen with organic
side chains attached to the silicon. It is softer, elastic,
biocompatible, relatively thromboresistant, and
stretches like vulcanized rubber. These devices made
long-term catheterization possible for the emerging
therapies of parenteral nutrition, bone marrow
transplantation, and hemodialysis. 
Venous thrombosis associated with central
catheters occurs in some form in the majority of
patients and can cause devastating morbidity, includ-
ing catheter occlusion, arm swelling, septic throm-
bophlebitis, superior vena cava syndrome, loss of
access sites, and pulmonary embolism. Mural
thrombus is found in at least a third of patients who
have had central catheters for a month or more.1
Fortunately, most patients remain asymptomatic, as
few as 5% of those with thrombosis on venogram
having symptoms or clinical signs of thrombosis.6
The reported incidence of venous thrombosis
depends on the method of detection, with the low-
est rates in studies that rely on clinical symptoms and
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Fig. 5. Macrophages adjacent to new capillary in lesion
from 1-week control animal. Arrowhead marks a multinu-
cleated giant cell. (original magnification · 184, hema-
toxylin and eosin stain).
Fig. 4. Photograph of 2-week specimen with catheter in place. Large mural thrombus lies in
distal superior vena cava, extending into right atrium. Fresh thrombus is present on surface.
Arrowhead marks caval-atrial junction.
the highest rates based on screening with venograms
or ultrasound. When venography is used, the inci-
dence of mural thrombus ranges from 28% to 54%.1
The rate would be even higher if all central veins
could be examined histologically, as we have done in
our animal model. This may explain, in part, why the
incidence of mural thrombosis in our control group
is much higher than that observed clinically. Another
possibility is that there is increased wall injury as a
result of the smaller size of the swine cava and per-
haps more catheter motion caused by vigorous activ-
ity of the animal. 
It is often assumed that thrombosis associated
with central venous catheters is a result of blood
interaction with the polymer surface. However, the
main cause of venous thrombosis is vascular injury,
which can begin either at the site of entry of the
catheter into the vein or at the tip of the catheter.7
The site and mode of catheter insertion also may
influence the occurrence and degree of vessel injury.
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Fig. 6. Gross photograph of lesion at catheter tip in 8-week control animal. Superior vena
cava has been opened, and in the process the catheter tip was dislodged from the lesion in
which it had been completely embedded. Cast of catheter tip can be seen in distal portion of
lesion (open arrow). The tip of the catheter remains covered with fibrotic tissue. Arrowhead
marks caval-atrial junction.
Fig. 7. Gross photograph of a loop catheter at 8 weeks. Catheter tip is completely free in the
lumen, and there is no gross evidence of vessel injury. Arrowhead marks caval-atrial junction.
In a rabbit model, obstructing thrombi were much
more common with rigid than with soft catheters.8
The site and mode of catheter insertion also may
influence the degree of vessel injury that occurs. Left
subclavian insertion has the highest rate of throm-
bosis, perhaps because the catheter abrades the ves-
sel wall where it turns to enter the superior vena
cava. It is recommended that the catheter tip be
placed at the junction of the superior vena cava and
the right atrium to reduce the incidence of perfora-
tion, thrombosis, and catheter dysfunction.3
Catheters are three times more likely to thrombose
if the tip is placed in the axillary, subclavian, or
innominate vein than if placed in the superior vena
cava (60% vs 20%).9
Repeated injury of the vessel wall is necessary to
cause thrombosis and wall thickening. A single limit-
ed endothelial injury made by abrasion with a nylon
loop of a rat carotid artery causes only temporary
platelet thrombosis, some smooth muscle cell prolif-
eration, and no intimal hyperplasia.10 In contrast,
chronic endothelial injury caused by an indwelling
polyethylene catheter in the rabbit carotid artery
causes fibrous and lipid-rich lesions similar to athero-
sclerosis.11 Similarly, rabbit veins completely denud-
ed of endothelium by a single balloon injury heal
rapidly, with complete reendothelialization and no
intimal hyperplasia.12 However, a chronic, indwelling
polyethylene catheter causes repeated injury with
deposition of platelets and formation of large platelet
and fibrin-rich thrombi at the catheter tip.13
Thrombus formation is accompanied by generation
of thrombin and release of cytokines from activated
platelets, such as platelet-derived growth factor,
which stimulate smooth muscle cell migration and
proliferation, forming lesions similar to intimal
hyperplasia. It has been suggested that repetitive
injury of the superior vena cava by the catheter tip
during cardiac pulsation causes mural thrombus at
this location.14 Thrombus in the superior vena cava
near the catheter tip can be documented by ultra-
sound and may be more prevalent than clinically sus-
pected when sought at autopsy.15,16
In our swine model we observed thrombosis
near the tip of indwelling central catheters in control
animals. Early thrombi were the typical mixed type
that form in the sluggish flow of the venous circula-
tion, consisting of a combination of red cells,
platelets, and fibrin.17 The thrombus organized into
a fibrotic lesion by infiltration of macrophages and
smooth muscle cells. This is similar to the lesion we
observed to cause occlusion of chronic indwelling
venous catheters in a rabbit model (unpublished
data). Ingrowth of smooth muscle cells into the fib-
rin mesh begins as soon as 2 days after thrombosis of
the vessel and eventually produces a lesion similar to
intimal hyperplasia.18 By 8 weeks the vena cava was
nearly occluded by hyperplasia and thrombus in
most animals. Wall thickening occurred primarily at
the catheter tip and was associated with ongoing
thrombosis at the site of endothelial injury. At 8
weeks all catheter tips were entrapped in this mural
lesion. Patency was not directly assessed in this
model, but entrapment of the tip may cause device
failure. This issue must be addressed in further stud-
ies. In our rabbit model loss of catheter patency was
associated with the development of similar large
mural lesions at the catheter tip (unpublished data).
We hypothesized that central vein thrombosis is
the result of chronic injury caused by motion of the
catheter tip against the vessel wall and that it could
be prevented by a catheter modification that stabi-
lizes the tip. We modified the catheter with a wire
loop coated in Silastic. The loop contacted the supe-
rior vena cava but remained motionless against the
wall. Test catheters eliminated the injury process for
up to 8 weeks. Very little injury response was found
where the loop contacted the vein wall, and the
catheter tip was in the center of the vessel and uni-
formly free of thrombus. There appeared to be no
significant difference in thrombogenicity of the
catheters themselves because fibrin sheaths sur-
rounding the catheter near the entry site were simi-
lar in control and loop catheters (data not shown).
Such a device may significantly reduce the incidence
of central vein thrombosis associated with central
venous catheters. This may lead to better long-term
catheter function, fewer episodes of catheter-related
infection, better preservation of vascular access sites,
and fewer symptoms of venous obstruction. Design
modifications are currently in progress to improve
ease of insertion and removal of catheters. Long-
term animal studies will be used to directly assess
patency, safety, and efficacy of this catheter design. 
CONCLUSION
Chronic indwelling catheters cause chronic
mechanical venous wall injury that results in active
thrombosis at the level of the catheter tip. Thrombus
organizes by infiltration of macrophages and smooth
muscle cells, resulting in a lesion similar to intimal
hyperplasia. By 8 weeks, the tip of the catheter
becomes entrapped in this lesion. This thrombosis
and catheter entrapment that results from chronic
mechanical venous wall injury can be prevented by a
catheter modification that stabilized the tip with a
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Dr. William Quinones-Baldrich. (Los Angeles, Calif.).
Dr. Kohler and his colleagues have performed an elegant
and relatively simple animal experiment in which they have
demonstrated perhaps one of the more important mecha-
nisms that leads to dysfunction and thrombotic complica-
tions of central venous catheters. The results of their inves-
tigation are rather convincing. Control animals almost uni-
versally had thrombosis at the catheter tip, which they
showed was most likely caused by whipping injury at the site
of the catheter tip. We have observed a similar process with
some endovascular interventions. For example, in atherec-
tomy procedures, the atherectomized site will look quite
well on follow-up; however, distal lesions are seen even a
few months after the intervention. This is likely the result of
a similar injury created by the guide wire moving within the
vessel wall and leading to intimal injury and intimal hyper-
plasia.
I believe the authors have made a significant contribu-
tion and have shown a likely fruitful direction in terms of
further improvement in central venous catheters.
I have several questions for the authors that concern
the future development of these catheters as they enter
into clinical trials:
First, I was impressed by the high incidence rate of
almost complete thrombosis of the superior vena cava in
your animals. This is something that we do not see clini-
cally and is likely the result of a much larger diameter cava
in patients. This is not to detract from the importance of
your findings, but rather to explore its clinical applicabili-
ty. Given that the junction of the superior vena cava and
the right atrium is much larger in adult patients at least,
what would you anticipate will be the size of the wire loop
necessary to stabilize the catheter tip, and how will this
affect both the insertion and removal of these catheters?
Second, did you see incorporation of the wire loop in
any of your animal experiments that suggests that such will
also occur in humans, leading to more difficulty in
removal of the catheter?
Third, is the position of the wire loop fixed, or will it
change depending on the actual orientation of the
DISCUSSION
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Silastic loop. Further studies are needed to determine
whether prevention of this lesion will improve
catheter function. Such a catheter may significantly
reduce the morbidity associated with these devices.
We gratefully acknowledge the expert technical assis-
tance of Susan Rozelle.
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catheter tip? I ask because I have some concern that if the
position of the catheter is variable, on occasion you may
have the jet of the infusate directed towards the vessel
wall. Is this something that is prevented by the wire loop,
or is it on occasion caused by it?
Finally, in contrast to your animal model, the experi-
ence in humans suggests that thrombus at the tip of the
catheter is the most common cause of catheter malfunc-
tion. Do you anticipate the stabilization by the wire loop
will also prevent this problem?
I congratulate the authors on an important addition in
the development of better central venous catheters. Given
the frequency with which these catheters are used, I believe
their contribution is significant. I enjoyed reading the man-
uscript and thank the authors for providing me with a copy.
Dr. Ted R. Kohler. Thank you for your thoughtful
comments.
You ask about the size of the loop catheter and point
out that the superior vena cava is larger in humans than in
swine. This means that a larger loop will be necessary to
stabilize the catheter, which may create problems in inser-
tion and removal of the device. That is a good point about
which we have thought. The current generation of this
catheter device uses a retractable wire mechanism instead
of a Silastic loop. The wire makes a loop near the tip of the
catheter and can be retracted into the catheter. It allows us
to vary the size of the loop and to more easily insert and
remove the catheter.
You wondered if the loop becomes incorporated in the
wall. We did not find incorporation of the loop in the wall,
so this should not be a problem in removing these catheters.
You also ask about the position of the catheter within
the loop—whether it is fixed centrally or might move to
one side and cause injury. If this occurred, the high-flow
jet associated with dialysis could be directed against the
wall and could cause injury. That is a good point. The loop
attaches to the catheter near the tip and holds it in the
center of the vessel. We have incorporated a similar cen-
tering mechanism in the current generation of the device.
Whether or not the jet of the infusate against the wall
causes injury is a good question, and one I hope we can pur-
sue in our next animal model in which we plan to simulate
more closely the clinical situation by infusing fluids through
the catheter device. Thank you for your comments.
Dr. Jeffrey Pearl (San Francisco, Calif.). I enjoyed this
paper. I have an interest in this subject. This particular
model that you have is a large catheter in a relatively small
animal. I wonder if it is a prone model and if you found
that the lesions were always on the dependent wall.
Dr. Kohler. That is a good question. If you recall the
diagram of the catheter being placed through the right
external jugular vein, you may have noticed that it came
across the midline toward the left. When we watch these
fluoroscopically, the catheter comes from the right side
across the midline, is angulated, and abuts the left wall of
the cava where the injury usually occurs.
Similarly, the site of catheter insertion affects the rate
of clinical thrombosis. Wall injury may be the reason that
left subclavian catheters have a higher rate of thrombosis
than those placed on the right. The wall may be where the
catheter turns from the innominate vein into the superior
vena cava.
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